GRAILvsUnitedHealth

GRAL and UNH stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$343.46

Value $312B

+4.04%
UNH's page

GRAIL (GRAL) has a market value of $4.5B and UnitedHealth (UNH) $312B. Over the last year, with dividends, GRAL moved +14.2% and UNH +14.2%. Dividend yield: GRAL none, UNH 2.64%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    GRAL$4.5B

    UNH$312B

    UNH is 69 times GRAL

  • Revenue, 12 months

    GRAL$167M

    UNH$450B

    UNH is 2,699 times GRAL

  • Net income, 12 months

    GRAL-$406M

    UNH$15.9B

  • Operating margin

    GRAL-347.3%

    UNH5.3%

    352.6 points apart

  • ROIC

    GRAL-18.6%

    UNH11.3%

    29.9 points apart

  • P/E

    GRAL–

    UNH19.6

  • Dividend yield

    GRAL0.0%

    UNH2.6%

    2.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

GRAL+14.2%

UNH+14.2%

50100150DecFebAprJunAugOct
Returns by period
PeriodGRALWith dividendsUNHWith dividends
1 year since November 19, 2025+14.2%Price +14.2%+14.2%Price +11.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

GRALGRAILUNHUnitedHealth

Valuation

GRALUNH
Valuation
Price$100.50$343.46
Market value$4.5B$312B
Enterprise value (EV)$3.7B$358B
P/E–19.6
P/E, 5-year median–25.0
P/B1.83.0
EV/EBIT–14.9
Free cash flow yield–7.3%

Results and growth

GRALUNH
Results and growth
Revenue, 12 months$167M$450B
Net income, 12 months-$406M$15.9B
Free cash flow, 12 months-$312M$22.8B
Earnings per share, 12 months-$9.44$17.52
Revenue growth, year on year17.2%11.8%
Revenue growth a year, past+38.4%over 3 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

GRALUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin-347.3%5.3%
Net margin-243.8%3.5%
ROIC-18.6%11.3%
ROE-16.5%15.5%

Balance sheet

GRALUNH
Balance sheet
Cash$788M$28.5B
Total debt$86M$74.3B
Net debt / EBITDA–1.6
Interest cover–6.2×

Dividends and buybacks

GRALUNH
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: GRAL or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, GRAIL or UnitedHealth?

By market value, UnitedHealth ($312B) is about 69.0 times GRAIL ($4.5B), at today's prices.

How did GRAL and UNH stock do over the last 1 years?

Since November 19, 2025, GRAL's price moved +14.2% and UNH's +11.2%. With dividends: GRAL +14.2% (+14.2% a year), UNH +14.2% (+14.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, GRAL or UNH?

The dividend yield at today's price is none for GRAIL and 2.64% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, GRAIL or UnitedHealth?

Over the last twelve months, the net margin was -243.8% for GRAIL and 3.5% for UnitedHealth, and the operating margin -347.3% and 5.3%. Revenue was $167M and $450B.

Which is the better investment, GRAIL or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.